Breaking News Instant updates and real-time market news.

ESPR

Esperion

$77.20

2.24 (2.99%)

05:06
01/22/18
01/22
05:06
01/22/18
05:06

Esperion downgraded to Neutral from Buy at Citi

Citi analyst Joel Beatty downgraded Esperion Therapeutics to Neutral while raising his price target for the shares to $96 from $77. Post the the bempedoic acid Phase 3 data in March, the stock will trade primary based on investor sentiment about whether Esperion will be acquired, Beatty tells investors in a research note. He's cautious about the likelihood of the company being acquired over the next 12 months.

ESPR Esperion
$77.20

2.24 (2.99%)

01/05/18
BOFA
01/05/18
UPGRADE
Target $76
BOFA
Buy
Esperion upgraded to Buy ahead of clinical trials at BofA/Merrill
BofA/Merrill analyst Ying Huang upgraded Esperion to Buy from Neutral and increased its price target to $76 from $60 on expectations for increased penetration in statin-tolerant patients. Phase 3 clinical trials are expected to report top-line results in 2018 and a positive outcome from Regeneron (REGN)/Sanofi's Praluent outcome trial should drive shares higher, the analyst contends.
01/16/18
STFL
01/16/18
NO CHANGE
Target $105
STFL
Buy
Esperion price target raised to $105 from $70 at Stifel
Stifel analyst Alex Schwartz noted that Esperion relayed at a conference last week that the company has received blinded adverse event data from their ongoing Phase 3 program for bempedoic acid. Based on the company's comments regarding the blinded data, Schwartz is increasingly positive on bempedoic acid's safety profile over 52 weeks, he tells investors. The analyst, who increased his estimated bempedoic acid WAC price and raised his view of the probability of success in the Phase 3 bempedoic acid monotherapy trials to 75%, increased his price target on Esperion shares to $105 from $70 and keeps a Buy rating on the name.
01/17/18
UBSW
01/17/18
NO CHANGE
Target $88
UBSW
Buy
Esperion price target raised to $88 from $62 at UBS
UBS analyst Carter Gould raised his price target to $88 from $62 to reflect higher peak sales for bempedoic acid and lower long-term tax rates. Gould reiterated his Buy rating on Esperion shares.
01/18/18
FBCO
01/18/18
INITIATION
Target $103
FBCO
Outperform
Esperion initiated with an Outperform at Credit Suisse
Credit Suisse analyst Martin Auster started Esperion Therapeutics with an Outperform rating and $103 price target. The analyst sees further room for upside following 2017's 425% rally as he believes the company's bempedoic acid franchise is well positioned.

TODAY'S FREE FLY STORIES

GPS

Gap

$28.28

-1.275 (-4.31%)

14:35
04/20/18
04/20
14:35
04/20/18
14:35
Options
Gap put volume heavy and directionally bearish »

Bearish flow noted in Gap…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PM

Philip Morris

$84.12

-1.53 (-1.79%)

14:33
04/20/18
04/20
14:33
04/20/18
14:33
Conference/Events
Philip Morris management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ALXN

Alexion

$105.99

-5.75 (-5.15%)

14:30
04/20/18
04/20
14:30
04/20/18
14:30
Recommendations
Alexion analyst commentary  »

Brazilian generic risk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

14:30
04/20/18
04/20
14:30
04/20/18
14:30
General news
Action Economics Survey results »

Action Economics Survey…

UCBI

United Community Banks

$32.40

0.27 (0.84%)

14:29
04/20/18
04/20
14:29
04/20/18
14:29
Syndicate
Breaking Syndicate news story on United Community Banks »

United Community Banks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 09

    May

HRTX

Heron Therapeutics

$30.40

0.6 (2.01%)

14:24
04/20/18
04/20
14:24
04/20/18
14:24
Recommendations
Heron Therapeutics analyst commentary  »

Helsinn CINV product no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

TGI

Triumph Group

$26.05

-0.2 (-0.76%)

14:20
04/20/18
04/20
14:20
04/20/18
14:20
Options
Put buying in Triumph Group »

Put buying in Triumph…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

14:17
04/20/18
04/20
14:17
04/20/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
04/20/18
04/20
14:16
04/20/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWTR

Twitter

$31.93

0.39 (1.24%)

14:14
04/20/18
04/20
14:14
04/20/18
14:14
Periodicals
Twitter bans ads from Kaspersky Lab, Reuters reports »

Twitter said it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$14.73

0.74 (5.29%)

, WAB

Wabtec

$88.35

4.61 (5.51%)

14:07
04/20/18
04/20
14:07
04/20/18
14:07
Periodicals
GE explores merging transport unit with Wabtec, Reuters says »

GE (GE) is looking into…

GE

General Electric

$14.73

0.74 (5.29%)

WAB

Wabtec

$88.35

4.61 (5.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 24

    Apr

  • 25

    Apr

  • 15

    May

  • 12

    Jun

KMB

Kimberly-Clark

$99.75

-3.59 (-3.47%)

14:05
04/20/18
04/20
14:05
04/20/18
14:05
Technical Analysis
Technical Earnings Preview: Kimberly-Clark near 5-year lows ahead of earnings »

The shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 27

    Apr

  • 30

    May

DVMT

Dell Technologies

$73.08

-0.81 (-1.10%)

14:05
04/20/18
04/20
14:05
04/20/18
14:05
Options
Dell Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

WEN

Wendy's

$17.23

-0.165 (-0.95%)

14:02
04/20/18
04/20
14:02
04/20/18
14:02
Hot Stocks
Wendy's announces 2020 goal of opening over 600 new restaurants globally »

The Wendy's Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

  • 30

    May

14:00
04/20/18
04/20
14:00
04/20/18
14:00
General news
Fed Governor Brainard did not break from the gradualist mantra »

Fed Governor Brainard did…

LITE

Lumentum

$59.70

-0.25 (-0.42%)

13:55
04/20/18
04/20
13:55
04/20/18
13:55
Options
Lumentum put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 29

    May

ALXN

Alexion

$104.44

-7.3 (-6.53%)

13:46
04/20/18
04/20
13:46
04/20/18
13:46
Hot Stocks
Alexion drops after Brazil AG says Soliris patent made public »

Shares of Alexion…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

AKRX

Akorn

$19.61

0.24 (1.24%)

13:45
04/20/18
04/20
13:45
04/20/18
13:45
Options
Akorn call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
04/20/18
04/20
13:45
04/20/18
13:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY topped…

TGT

Target

$70.52

-0.45 (-0.63%)

13:35
04/20/18
04/20
13:35
04/20/18
13:35
Options
Target put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

IWM

iShares Trust Russell 2000 Index Fund

$155.75

-0.65 (-0.42%)

, RUT

Russell 2000 Index

13:35
04/20/18
04/20
13:35
04/20/18
13:35
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

At time of writing, the…

IWM

iShares Trust Russell 2000 Index Fund

$155.75

-0.65 (-0.42%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$50.43

-0.915 (-1.78%)

, XLRE

Real Estate SPDR

$30.25

-0.25 (-0.82%)

13:33
04/20/18
04/20
13:33
04/20/18
13:33
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the last five days,…

XLP

Consumer Staples Sector SPDR

$50.43

-0.915 (-1.78%)

XLRE

Real Estate SPDR

$30.25

-0.25 (-0.82%)

XLK

Technology Select Sector SPDR

$66.26

-0.89 (-1.33%)

XLE

Energy Select Sector SPDR

$73.29

-0.37 (-0.50%)

XLB

S&P Select Materials SPDR

$58.95

-0.41 (-0.69%)

XLF

Financial Select Sector

$27.94

0.065 (0.23%)

SPY

SPDR S&P 500 ETF Trust

$266.75

-2.09 (-0.78%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$50.25

0.5 (1.01%)

13:25
04/20/18
04/20
13:25
04/20/18
13:25
Options
Scientific Games call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

ALXN

Alexion

$110.26

-1.48 (-1.32%)

13:21
04/20/18
04/20
13:21
04/20/18
13:21
Periodicals
Brazil can produce generic Soliris after breaking Alexion patent, Bloomberg says »

Brazil's Attorney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

WAB

Wabtec

$82.74

-1 (-1.19%)

, GE

General Electric

$14.46

0.47 (3.36%)

13:18
04/20/18
04/20
13:18
04/20/18
13:18
Hot Stocks
Wabtec rises after report of talks for GE rail business deal »

Shares of Wabtec (WAB)…

WAB

Wabtec

$82.74

-1 (-1.19%)

GE

General Electric

$14.46

0.47 (3.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 24

    Apr

  • 25

    Apr

  • 15

    May

  • 12

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.